NCT02861430View on ClinicalTrials.gov

Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Colon CancerLymph NodeSentinel Node
Interventions
PROCEDURE

Immunochemistry and molecular biology on sentinel lymph node specimen

Trial Locations (1)

25030

CHRU Besancon, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02861430 - Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology | Biotech Hunter | Biotech Hunter